These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30073540)

  • 1. Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction.
    Rossello X; Piñero A; Fernández-Jiménez R; Sánchez-González J; Pizarro G; Galán-Arriola C; Lobo-Gonzalez M; Vilchez JP; García-Prieto J; García-Ruiz JM; García-Álvarez A; Sanz-Rosa D; Ibanez B
    J Cardiovasc Transl Res; 2018 Aug; 11(4):310-318. PubMed ID: 30073540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes.
    García-Prieto J; García-Ruiz JM; Sanz-Rosa D; Pun A; García-Alvarez A; Davidson SM; Fernández-Friera L; Nuno-Ayala M; Fernández-Jiménez R; Bernal JA; Izquierdo-Garcia JL; Jimenez-Borreguero J; Pizarro G; Ruiz-Cabello J; Macaya C; Fuster V; Yellon DM; Ibanez B
    Basic Res Cardiol; 2014 Jul; 109(4):422. PubMed ID: 24951958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH).
    Pouleur AC; Anker S; Brito D; Brosteanu O; Hasenclever D; Casadei B; Edelmann F; Filippatos G; Gruson D; Ikonomidis I; Lhommel R; Mahmod M; Neubauer S; Persu A; Gerber BL; Piechnik S; Pieske B; Pieske-Kraigher E; Pinto F; Ponikowski P; Senni M; Trochu JN; Van Overstraeten N; Wachter R; Balligand JL
    ESC Heart Fail; 2018 Oct; 5(5):830-841. PubMed ID: 29932311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension.
    García-Álvarez A; Pereda D; García-Lunar I; Sanz-Rosa D; Fernández-Jiménez R; García-Prieto J; Nuño-Ayala M; Sierra F; Santiago E; Sandoval E; Campelos P; Agüero J; Pizarro G; Peinado VI; Fernández-Friera L; García-Ruiz JM; Barberá JA; Castellá M; Sabaté M; Fuster V; Ibañez B
    Basic Res Cardiol; 2016 Jul; 111(4):49. PubMed ID: 27328822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotective Effects of Beta3-Adrenergic Receptor (β3-AR) Pre-, Per-, and Post-treatment in Ischemia-Reperfusion.
    Salie R; Alsalhin AKH; Marais E; Lochner A
    Cardiovasc Drugs Ther; 2019 Apr; 33(2):163-177. PubMed ID: 30729348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion.
    Santos-Gallego CG; Vahl TP; Goliasch G; Picatoste B; Arias T; Ishikawa K; Njerve IU; Sanz J; Narula J; Sengupta PP; Hajjar RJ; Fuster V; Badimon JJ
    Circulation; 2016 Mar; 133(10):954-66. PubMed ID: 26826180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Intracoronary Metformin on Myocardial Infarct Size in Swine.
    Techiryan G; Weil BR; Palka BA; Canty JM
    Circ Res; 2018 Sep; 123(8):986-995. PubMed ID: 30355033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the Timing of Metoprolol Administration During STEMI on Infarct Size and Ventricular Function.
    García-Ruiz JM; Fernández-Jiménez R; García-Alvarez A; Pizarro G; Galán-Arriola C; Fernández-Friera L; Mateos A; Nuno-Ayala M; Aguero J; Sánchez-González J; García-Prieto J; López-Melgar B; Martínez-Tenorio P; López-Martín GJ; Macías A; Pérez-Asenjo B; Cabrera JA; Fernández-Ortiz A; Fuster V; Ibáñez B
    J Am Coll Cardiol; 2016 May; 67(18):2093-2104. PubMed ID: 27052688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model.
    Ichimura K; Matoba T; Nakano K; Tokutome M; Honda K; Koga J; Egashira K
    PLoS One; 2016; 11(9):e0162425. PubMed ID: 27603665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
    Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
    J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human β3-Adrenoreceptor is Resistant to Agonist-Induced Desensitization in Renal Epithelial Cells.
    Milano S; Gerbino A; Schena G; Carmosino M; Svelto M; Procino G
    Cell Physiol Biochem; 2018; 48(2):847-862. PubMed ID: 30032151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart Rate Reduction With Ivabradine Protects Against Left Ventricular Remodeling by Attenuating Infarct Expansion and Preserving Remote-Zone Contractile Function and Synchrony in a Mouse Model of Reperfused Myocardial Infarction.
    O'Connor DM; Smith RS; Piras BA; Beyers RJ; Lin D; Hossack JA; French BA
    J Am Heart Assoc; 2016 Apr; 5(4):. PubMed ID: 27107133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of a β3-adrenoceptor agonist on bladder function in a rat model of chronic bladder ischemia.
    Sawada N; Nomiya M; Hood B; Koslov D; Zarifpour M; Andersson KE
    Eur Urol; 2013 Oct; 64(4):664-71. PubMed ID: 23838637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of reperfusion post-infarction ventricular remodeling: new MRI insights.
    Springeling T; Uitterdijk A; Rossi A; Gorsse-Bakker C; Wielopolski PA; van der Giessen WJ; Krestin GP; de Feyter PJ; Duncker DJ; van Geuns RJ
    Int J Cardiol; 2013 Nov; 169(5):354-8. PubMed ID: 24182681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction.
    Ye Y; Birnbaum GD; Perez-Polo JR; Nanhwan MK; Nylander S; Birnbaum Y
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1805-14. PubMed ID: 26044583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bloodless reperfusion with the oxygen carrier HBOC-201 in acute myocardial infarction: a novel platform for cardioprotective probes delivery.
    García-Ruiz JM; Galán-Arriola C; Fernández-Jiménez R; Aguero J; Sánchez-González J; García-Alvarez A; Nuno-Ayala M; Dubé GP; Zafirelis Z; López-Martín GJ; Bernal JA; Lara-Pezzi E; Fuster V; Ibáñez B
    Basic Res Cardiol; 2017 Mar; 112(2):17. PubMed ID: 28188434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of the master regulator transcription factor Egr-1 with catalytic oligonucleotides reduces myocardial injury and improves left ventricular systolic function in a preclinical model of myocardial infarction.
    Rayner BS; Figtree GA; Sabaretnam T; Shang P; Mazhar J; Weaver JC; Lay WN; Witting PK; Hunyor SN; Grieve SM; Khachigian LM; Bhindi R
    J Am Heart Assoc; 2013 Jul; 2(4):e000023. PubMed ID: 23902638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexarelin targets neuroinflammatory pathways to preserve cardiac morphology and function in a mouse model of myocardial ischemia-reperfusion.
    McDonald H; Peart J; Kurniawan ND; Galloway G; Royce SG; Samuel CS; Chen C
    Biomed Pharmacother; 2020 Jul; 127():110165. PubMed ID: 32403043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice.
    Devarakonda T; Mauro AG; Guzman G; Hovsepian S; Cain C; Das A; Praveen P; Hossain MA; Salloum FN
    J Am Heart Assoc; 2020 Apr; 9(8):e015748. PubMed ID: 32295457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Mitochondrial Fission Using Mdivi-1 in A Clinically Relevant Large Animal Model of Acute Myocardial Infarction: A Pilot Study.
    Ong SB; Kwek XY; Katwadi K; Hernandez-Resendiz S; Crespo-Avilan GE; Ismail NI; Lin YH; Yap EP; Lim SY; Ja KPMM; Ramachandra CJA; Tee N; Toh JJ; Shim W; Wong P; Cabrera-Fuentes HA; Hausenloy DJ
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31443187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.